Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1630704

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1630704

Spatial Omics Market Size, Share, Growth Analysis, By Technology (Spatial Transcriptomics, Spatial Genomics), By Product (Instruments, Consumables), By Workflow, By Sample Type, By End-use, By Region - Industry Forecast 2025-2032

PUBLISHED:
PAGES: 242 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Global Spatial Omics Market size was valued at USD 365.0 billion in 2023 and is poised to grow from USD 402.96 billion in 2024 to USD 889.23 billion by 2032, growing at a CAGR of 10.4% during the forecast period (2025-2032).

The spatial omics market is experiencing significant growth, driven by the increasing prevalence of genetic disorders, advancements in sequencing technologies, and heightened investment in innovative research. This transformative approach shifts focus from decoding gene sequences to analyzing the spatial positioning and interactions of cell types and biomarkers. Leading companies in the field are delivering solutions that quantify approximately 1,800 RNA targets, effectively merging molecular analysis with spatial data from tissues. This spatial genomic information is proving essential for developing diagnostic biomarkers that aid in disease identification and management. As such, spatial omics technology is crucial for understanding complex biological mechanisms, including tissue organization and cellular regulation, ultimately enhancing therapeutic strategies and clinical outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Spatial Omics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Spatial Omics Market Segmental Analysis

Global Spatial Omics Market is segmented by Technology, Product, Workflow, Sample Type, End-use and region. Based on Technology, the market is segmented into Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics. Based on Product, the market is segmented into Instruments, Consumables and Software. Based on Workflow, the market is segmented into Sample Preparation, Instrumental Analysis and Data Analysis. Based on Sample Type, the market is segmented into FFPE and Fresh Frozen. Based on End-use, the market is segmented into Academic & Translational Research Institutes and Pharmaceutical & Biotechnology Companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Spatial Omics Market

The Global Spatial Omics market is poised for significant growth, driven primarily by the increasing prevalence of genetic disorders that tend to be hereditary. As uncertainties surrounding health conditions rise, there is a growing desire among individuals to understand and detect these disorders through advanced omics technologies. This demand underscores the importance of spatial omics tools, which facilitate the identification and analysis of genetic anomalies within various biological samples. Consequently, the need for these innovative diagnostics and research solutions is propelling the expansion of the spatial omics market, making it a critical sector in addressing genetic health challenges.

Restraints in the Global Spatial Omics Market

The Global Spatial Omics market faces significant restraints that may impede its growth prospects. One major challenge is the shortage of skilled professionals with expertise in this emerging research domain, which is expected to limit advancements and further developments. Since Spatial Omics is still a relatively novel field, there is a lack of widespread acceptance and understanding, leading to cautious adoption among researchers and institutions. This limited recognition can stifle innovation and investment, ultimately hindering the overall expansion of the market during the forecast period. Addressing these issues will be crucial to unlocking the full potential of Spatial Omics.

Market Trends of the Global Spatial Omics Market

The Global Spatial Omics market is currently witnessing a significant uptick as the demand for advanced diagnostic tools grows, particularly in oncology. The innovative spatial omics techniques, which effectively elucidate the complex mechanisms governing cell interactions at tumor boundaries, are gaining traction due to their potential to enhance early malignancy detection. This trend is fueled by increasing investments in research and development, coupled with rising prevalence of cancers worldwide. Furthermore, the integration of spatial omics with existing genomic and transcriptomic technologies promises breakthroughs in personalized medicine, paving the way for a robust market expansion in the coming years.

Product Code: SQMIG35H2069

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Case Study Analysis

Global Spatial Omics Market Size by Technology & CAGR (2025-2032)

  • Market Overview
  • Spatial Transcriptomics
  • Spatial Genomics
  • Spatial Proteomics

Global Spatial Omics Market Size by Product & CAGR (2025-2032)

  • Market Overview
  • Instruments
    • By Mode
    • Automated
    • Semi-automated
    • Manual
    • By Type
    • Sequencing Platforms
    • IHC
    • Microscopy
    • Flow Cytometry
    • Mass Spectrometry
    • Others
  • Consumables
  • Software
    • Bioinformatics Tools
    • Imaging Tools
    • Storage & Management Databases

Global Spatial Omics Market Size by Workflow & CAGR (2025-2032)

  • Market Overview
  • Sample Preparation
  • Instrumental Analysis
  • Data Analysis

Global Spatial Omics Market Size by Sample Type & CAGR (2025-2032)

  • Market Overview
  • FFPE
  • Fresh Frozen

Global Spatial Omics Market Size by End-use & CAGR (2025-2032)

  • Market Overview
  • Academic & Translational Research Institutes
  • Pharmaceutical & Biotechnology Companies

Global Spatial Omics Market Size & CAGR (2025-2032)

  • North America (Technology, Product, Workflow, Sample Type, End-use)
    • US
    • Canada
  • Europe (Technology, Product, Workflow, Sample Type, End-use)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Technology, Product, Workflow, Sample Type, End-use)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Technology, Product, Workflow, Sample Type, End-use)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Technology, Product, Workflow, Sample Type, End-use)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • 10x Genomics (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Illumina (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fluidigm Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Akoya Biosciences (formerly PerkinElmer) (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • S2 Genomics, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • RareCyte, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ZEISS Group (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Miltenyi Biotec (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Techne Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Visiopharm (Denmark)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Indica Labs, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Oxford Nanopore Technologies (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Takara Bio Inc. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!